Clare Laboratories Private Limited
About Clare Laboratories Private Limited
Data last updated:
Clare Laboratories Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 January 2023.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2023PTC138569. Its GSTIN is 24AAKCC8501B1Z4 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Digvijaysinh Bharatsinh Jadeja and Tejas Laxmanbhai Karmata.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bl No – A31 Janki Park Opp Hemkunj Kalawad Road, Rajkot, Gujarat, India – 360005.
As per the financials filed for FY 2025, the company reported a revenue of ₹13,390, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹26.59 Lakh and EBITDA of -₹26.54 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Clare Laboratories Private Limited's registered office is in Rajkot, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBl No – A31 Janki Park Opp Hemkunj Kalawad Road, Rajkot, Gujarat, India – 360005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Clare Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Clare Laboratories Private Limited
FY 2025 filings availableClare Laboratories Private Limited reported revenue of ₹13,390 (down 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 80% in the latest year. EBITDA fell 342% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹26.54 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹26.59 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Clare Laboratories Private Limited, buy the company report.
Board of directors of Clare Laboratories Private Limited
Clare Laboratories has 16 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Digvijaysinh Bharatsinh Jadeja Also directs: Shree Gokul Multispeciality Services LLP, Saurashtra Critical Care LLP, Transoceanic Healthcare LLP and 3 more | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
| Tejas Laxmanbhai Karmata Also directs: Shree Gokul Multispeciality Services LLP, Saurashtra Critical Care LLP, Transoceanic Healthcare LLP and 3 more | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
| Bipinbhai Bhanjibhai Kanani | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
| Tejas Arjunbhai Motivaras Also directs: Shree Gokul Multispeciality Services LLP, Saurashtra Critical Care LLP, Transoceanic Healthcare LLP and 3 more | Director | 25 Mar 2024 | 2 Years 7 Months | Current |
| Dipesh Anilbhai Gohil Also directs: 3D Hospicare LLP | Director | 25 Mar 2024 | 2 Years 7 Months | Current |
| Uttpal Prakashchandra Modha Also directs: Shree Gokul Multispeciality Services LLP | Director | 25 Mar 2024 | 2 Years 7 Months | Current |
Peer comparison
Clare Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jagdamba Global Chemtech Private Limited | ₹14,064 (FY 2023) | New Delhi, Delhi, India | ||||
| Genotech Health and Life Sciences Private Limited | ₹13,987 (FY 2024) | 5.0% | Hyderabad, Telangana, India | |||
| Varnmed Healthcare Private Limited | ₹13,594 (FY 2024) | Haridwar, Uttarakhand, India | ||||
| Vedic Formulations Private Limited | ₹13,589 (FY 2021) | -97.0% | Chandigarh, India | |||
| Biomolecules Life Science Private Limited | ₹13,451 (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Clare Laboratories Private Limitedthis company | ₹13,390 (FY 2025) | -₹26.59 Lakh | -80.0% | Rajkot, Gujarat, India | ||
| Hestia Pharma Private Limited | ₹13,250 (FY 2023) | -99.0% | Bangalore, Karnataka, India | |||
| Maharaja Health Care Private Limited | ₹13,240 (FY 2025) | 14.0% | Jaipur, Rajasthan, India | |||
| Bright Drug Industries Private Limited | ₹13,218 (FY 2025) | 32.0% | Indore, Madhya Pradesh, India | |||
| Nutalent Pharma Private Limited | ₹13,161 (FY 2025) | -67.0% | Chennai, Tamil Nadu, India | |||
| Care Form Labs Private Limited | ₹13,095 (FY 2025) | -100.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Clare Laboratories Private Limited, buy the company report.
Auditor
Clare Laboratories Private Limited is audited by RANPURA DESAI AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANPURA DESAI AND CO. | FY 2023 | 117476W |
Shareholding
The shareholding of Clare Laboratories Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Clare Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Clare Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clare Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Clare Laboratories Private Limited has 1 active EPFO establishment as of Mar 23, 2024.
GST
Clare Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCC8501B1Z4 | Gujarat | Active | 22 Dec 2023 |
To see the full GST registrations and return filing status of Clare Laboratories Private Limited, buy the company report.
Recent activity
Clare Laboratories Private Limited has 16 board changes on record since 2023: 16 appointments. The latest: Anjanaben Bhaveshbhai Karmata was appointed as Director on 24 Jul 2024.
7 earlier events are in the company report.
Frequently asked questions
Clare Laboratories is an active private limited company based in Rajkot, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 January 2023 (3+ years old) and is registered under CIN U24110GJ2023PTC138569.
Clare Laboratories has 16 current directors:
- Digvijaysinh Bharatsinh Jadeja - Director
- Tejas Laxmanbhai Karmata - Director
- Bipinbhai Bhanjibhai Kanani - Director
- Tejas Arjunbhai Motivaras - Director
- Dipesh Anilbhai Gohil - Director
- Uttpal Prakashchandra Modha - Director
- Vishal Prakashbhai Modha - Director
- Darshanbhai Girishchandra Shukla - Director
- Vipul Pradipkumar Parekh - Director
- Almasben Nuruddin Vindhani - Director
- Bharat Veljibhai Kanani - Director
- Pankaj Kurjibhai Santoki - Director
- Ayush Asheshbhai Mandavia - Director
- Anjanaben Bhaveshbhai Karmata - Director
- Pankajkumar Babulal Nariya - Director
- Jay Narendrabhai Kothari - Director
The latest financial statements of Clare Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Clare Laboratories is 24AAKCC8501B1Z4, registered in Gujarat.
The CIN (Corporate Identification Number) of Clare Laboratories is U24110GJ2023PTC138569. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clare Laboratories was incorporated on 20 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Clare Laboratories by revenue are Jagdamba Global Chemtech Private Limited, Genotech Health and Life Sciences Private Limited, Varnmed Healthcare Private Limited, Vedic Formulations Private Limited, Biomolecules Life Science Private Limited and 5 more, all in the Pharma industry (Formulations).
Anjanaben Bhaveshbhai Karmata was appointed as Director on 24 Jul 2024. Jay Narendrabhai Kothari was appointed as Director on 24 Jul 2024. Pankajkumar Babulal Nariya was appointed as Director on 24 Jul 2024. Clare Laboratories has 16 board changes on record in total.
The registered office of Clare Laboratories is at Bl No – A31 Janki Park Opp Hemkunj Kalawad Road, Rajkot, Gujarat, India – 360005.
Clare Laboratories operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Clare Laboratories is compliant as of 26 September 2026. The company is actively filing with the Registrar of Companies.